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Abstract 
 
The study seeks to evaluate nanoparticles based on chitosan for enhanced delivery of ampicillin in 
plasmid-mediated drug resistance. Serial dilutions of a mixed population of E. coli was plated on nutrient 
agar and streaked on Replica-plate 25 random colonies using MacConkey agar with or without ampicillin 
(100 µg/ml) daily for 96 h. Nanoparticles were prepared by cross-linking chitosan with sodium 
tripolyphosphate with ampicillin trihydrate adsorbed. Three different batches were prepared for 
optimization. The nanoparticles were optimized based on encapsulation efficiency, in vitro drug release, 
pH stability and microbiological assay using two laboratory strains of E. coli. Increased resistance to 
ampicillin due to possible plasmid transfer was established in vitro after 96 h. The encapsulation 
efficiency of the three batches was between 21-57 %. The drug release showed a burst effect and slow 
extended release over 8 h and reached a peak of about 19 % release at the 6 and 7 h in Batch A, B and 
C. The pH of the particles was stable over a period of 6 d. The nanoparticles containing only 0.075 mg of 
ampicillin dropped in an agar well plate inoculated with 1 ml of E. coli J62 lac pro trp hispFlac::Tn3 (AmpR) 
gave an IZD of ≥ 25 mm. Chitosan nanoparticles holds good potentials in potentiating the antibacterial 
effect of ampicillin against possible plasmid-mediated drug resistance. 
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The emergence of antibiotic resistance 
worldwide has become an old but unsolved 
problem. In some bacteria, resistance is 
encoded by conjugative plasmids expressing 
sex-pili that can readily spread resistance 
through bacterial populations (Colom et al., 
2019). Pathogenic Escherichia coli causes 
enteric diseases such as diarrhoea, urinary tract 
infections and meningitis. Ampicillin (AMP), an 
extended spectrum penicillin, is widely used to 
treat human and livestock E. coli infections, but 
recently its resistance rate has increased (Li et 
al., 2019). It is effective against Gram-positive 
and Gram-negative bacteria. Ampicillin works on 
the active replicating stage of bacteria, inhibiting 
the synthesis of bacterial cell wall (Li et al., 
2019). Pharmaceutical companies are already 
daunted with the rapid spread of resistance to 
multiple and unrelated drugs. Development of 
new drugs to combat the global threat seems to 
have become an unnecessary course to follow 
since there is that high probability of microbial 
resistance after some years. The search for 
alternatives has led researchers to look at drug 
delivery systems with antibacterial properties 
such as chitosan. Chitosan is biodegradable, 
mucoadhesive, non-toxic and used widely as an 
antibacterial agent (Kong et al., 2010). It has 
been used in potentiating the biocidal efficacy of 
antimicrobial compounds. The spectrum of 
activity of chitosan includes fungi, yeast, Gram-
negative and Gram-positive bacteria (Raafat and 
Sahl, 2009). The mechanism of action is the 
interaction between positively-charged chitosan 
molecules and negatively-charged microbial cell 
membranes. There is an electrostatic force 
between the protonated NH3+ groups on the 
chitosan molecules dissolved in acetic acid and 
the negative residues presumably by competing 
with Ca2+ for electronegative sites on the 
membrane surface (Goy et al., 2009). In this 
study, we used a highly self-transmissible Flac 
plasmid tagged with Tn3 (AmpR) in a laboratory 
E. coli strain. The transfer rate of this Flac 
plasmid is 95.7 % ± 3.5 (Colom et al., 2019). 
The plasmid has AMR genes. So, we sought in 
this study to evaluate the potentiation of the 
antibacterial effect of ampicillin by chitosan 
polymer against this E. coli J62 lac pro trp 
hispFlac::Tn3 (AmpR) 
MATERIALS AND METHODS 
Microorganisms 
Laboratory model of E. coli J62 lac pro trp 
hispFlac::Tn3 (AmpR). Donation from Professor 




Preparation of nanoparticles 
 
Chitosan particles were prepared by solubilizing 
250 mg of chitosan (Sigma Aldrich, Darmstadt, 
Germany) in 2 % v/v acetic acid (Sigma Aldrich, 
Darmstadt, Germany). Chitosan nanoparticles 
were formed by dropwise addition of 1 % w/v 
sodium tripolyphosphate (Sigma Aldrich, 
Darmstadt, Germany) to 2.5 %w/v chitosan 
particles using a 23-gauge needle. This was 
done on a magnetic stirrer (Julabo, Allentown, 
PA, USA) at 150 rpm for 30 min. The chitosan 
nanoparticles were incubated with 2.5 % w/v of 
ampicillin trihydrate (Elbe Pharma, Lagos, 
Nigeria).  This was done in three batches 
namely Type A, Type B and Type C as shown in 
Table 1 (Onuigbo et al., 2016). 
 
 

















A 7       2  1 150 15 
B 6 3 1 200 20 
C 5 4   1 300 30 
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Determination of Percent encapsulation 
efficiency 
To determine encapsulation efficiency, the 
different formulations (Batch A, Batch B and 
Batch C) were centrifuged at 4000 rpm for 30 
min and 2 ml of the supernatant was withdrawn 
using a syringe. Appropriate dilution was 
prepared and the solutions analyzed by UV-
spectrophotometer at a wavelength of 245 nm. 
The absorbances of the supernatant were 
recorded. From the absorbances, concentrations 
of the supernatant were obtained using the 
calculated molar absorptivity (from the Beer’s 
plot). The encapsulation efficiency was 




× 100 ……..equation 1 
pH assessment of the formulations 
The different batches of nanoparticles were 
stored at room temperature for 6 d. The pH of 
the solutions was determined using a digital pH 
meter (JENWAY, Eaton Socon, UK). This was 
repeated three times and the average pH taken 
to determine its stability on storage. 
 In-vitro Drug release study   
The dissolution medium consisted of 100 mL of 
freshly prepared PBS maintained at 37 ± 1℃ 
using a heater/magnetic stirrer. The 
polycarbonate dialysis membrane used was pre-
treated by soaking it in the dissolution media for 
24 h. For the study, 2 mL of the formulated 
chitosan nanoparticles was placed in the dialysis 
membrane securely tied to a thermo-resistant 
thread and then immersed in the dissolution 
medium under agitation provided by the 
magnetic stirrer at 150 rpm. At pre-determined 
time intervals, 2 mL portions of the dissolution 
medium were withdrawn, filtered and analysed 
spectrophotometrically (UV/VIS 
spectrophotometer (Spectrumlab 752S, 
California, USA) at 245 nm. For each sample 
withdrawn, an equivalent volume (2 mL) of 
phosphate buffer maintained at the same 
temperature was added to the contents of the 
dissolution medium to maintain sink conditions 
throughout the release period. The amount of 
drug released at each time interval was 
determined with reference to the standard 
Beer’s plot for ampicillin in phosphate buffer 
(Umeyor et al., 2012) 
 
% Drug released =
Conc (from Beer′s plot)
Conc of drug in formulation
×100…… 
……………equation 2 
Percent plasmid transfer  
 
An overnight culture of a mixed population of E. 
coli containing E. coli J62 lac pro trp 
hispFlac::Tn3 (AmpR) was prepared in 10 ml of 
sterile nutrient broth (Lab M, Lancashire, UK). 
This was diluted 1/100 with nutrient broth and 
then incubated for 2 h at 37 ℃ (log phase). 
Decimal dilutions to 10-6 was prepared on 
nutrient agar and incubated for 24 h at 37 ℃, 
then original and diluted cultures were counted. 
Replica-plated 25 random colonies on 
MacConkey agar (Lab M, Lancashire, UK) with 
or without ampicillin (100 µg/mL) (control) were 
prepared. This procedure was repeated daily for 
3 days with the 1/100 broth dilution and 
percentage resistance recorded (Colom et al., 
2019). 
Microbiological assay on different bacterial 
strains 
 
Molten MacConkey agar (19 mL) was inoculated 
with 1 mL of Escherichia coli and E. coli 
Flac∴Tn3 broth cultures, respectively. It was 
mixed thoroughly, poured into Petri dishes, and 
rotated to ensure even distribution of the 
organism. The agar plates were allowed to set 
and a sterile cork-borer (8 mm diameter) was 
used to cut three wells in each of the agar 
medium plate representing the three isolates. 
The three different batches of nanoparticles 
were prepared and used as follows: 2 drops of 
the formulations were added into the different 
holes in each of the plates using sterile Pasteur 
pipettes. The plates were allowed to stand at 
room temperature for 15 min to enable the 
samples diffuse into the medium before 
incubating at 37 ℃ for 24 h. The inhibition zone 
diameters were carefully measured and 
recorded.  
 
RESULTS AND DISCUSSION 
pH 
The pH of the nanoparticles ranged from 4.29 to 
4.34 in Batch A, 4.29 to 4.33 in Batch B and 
then in Batch C, it was between 4.36 and 4.39 
as seen in Table 2. The variation in pH for the 
three groups was minimal. The minimal pH 
variation showed that the method produced 
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particles of good stability. There was also no 
discoloration or odour or aggregation of the 
particles under storage conditions. Modification 
of pH has been shown to have effect on 
encapsulation efficiency and release of drug 
from chitosan microparticles. Low pH of sodium 
tripolyphosphate (TPP) resulted in slower 
felodipine release from microparticles. (Yongmei 
and Yumin, 2003). Chitosan is poorly water 
soluble at neutral or alkaline pH. Ionization of 
chitosan decreases with increase in pH leading 
to weaker cross-linking density (Khan et al., 
2010). It is only soluble at mild acidic pH hence 
the dissolution in 2 % acetic acid. Upon 
dissolution it is protonated with a free -NH3+ site 
which has a low pH. Sodium tripolyphosphate 
(Na5P3O10) dissociates in water to produce both 
tripolyphosphoric acid (H5P3O10) which is a weak 
polyprotic acid and OH-. The cross-linking of 
chitosan with sodium tripolyphosphate is called 
ionic gelation. The –OH- or tripolyphosphoric 
ions competitively react ionically with the –NH3+ 
binding site by deprotonation and covalent 
bonds respectively (Shihui et al., 2011).  
Prabaharan and Mano (2005) reported that high 
porosity of the chitosan microspheres was 
obtained with cross-linking with TPP solution of 
pH 8.6. The porous microspheres could be 
modified chemically by adding additives like 
carboxyl, hydrophobic acyl and quaternary 
ammonium groups) acting as hydrophobic 
barrier on the surface of the nanoparticles 
hindering leaching or penetration of water 
(Saeed et al., 2020). Basic conditions 
deprotonate chitosan particles forcing it to lose 
stability and form aggregates (Saeed et al., 
2020). 
 




 1st Day 2nd Day 6th Day 
A 4.29 4.30 4.34 
B 4.29 4.30 4.34 
C 4.39 4.39 4.36 
    
    
Percent encapsulation efficiency (PEE) 
In the percent encapsulation efficiency, Batch C 
had the highest PEE followed by Batch B and 
least was Batch A. Batch B had a PEE > 50 %. 
This formulation was set at a stirring speed of 
300 rpm and stirring time of 30 min. The high 
PEE could be attributed to the higher amount of 
TPP which produced a strong and closer 
network with the chitosan in a hydrogen bonding 
(Yongmei and Yumin, 2003). TPP is used in 
cross-linking chitosan thereby improving the 
mechanical strength of the gel. Sodium 
tripolyphosphate has a high negative charge 
density and the more the amount added, the 
stronger the matrix (Bangun et al., 2018) and 
more resistant to erosion (Saeed et al., 2020).  
Concentration of cross-linking agent, stirring 
time and speed are important factors in 
entrapment of drug (Razak et al., 2017). This 
high drug encapsulation is an indication of the 
efficiency of the ionic gelation method and the 
effect of chitosan:TPP ratio on preparation 
process. It has been observed that the 
microparticles do not form spherical shapes at 
higher stirring speed like 1500 rpm but at lower 
stirring speeds. Tilkan and Ozdemir (2018) 
observed that the optimum microsphere 
formation was a stirring speed of 100 rpm. He 
also observed that the duration of cross-linking 
time for microparticle formation was 30 min. 
High encapsulation efficiency close to 100 % 
has been achieved with ionotropic gelation 
method when interactions between chitosan and 










In-vitro drug release 
Batch C had a burst release in the first hour of 
release which became stable for the next 6 h 
which may be due to gradual penetration of 
dissolution medium into the matrices followed by 
a rise at the 7 h and then decrease which could 
be associated with degradation of the cross-
linker. This result also correlates with the 
percent encapsulation efficiency with Batch C > 
B > A. Batch B had a lower release than A at the 
first hour and then a rise and fall which peaked 
at the 6 h releasing the remaining drug 
entrenched inside the matrices. Batch C had the 
lowest release at the first hour which was 
sustained for the next two hours and then rose 
and peaked at the 6 h with an equal percent 
release as Batch C and then a decrease. For 
Batch C, the percentage release oscillates 
between 14 and 19 %. For Batch B, the percent 
release is between 10 and 17 % while for Batch 




Percent plasmid transfer  
The antimicrobial resistance test showed 100 % 
growth of the mixed population of E. coli in all 
the 25 replica random control plates for four 
consecutive days. In the plates containing 100 
µg/ml of the pure ampicillin drug, there was 16 
% ampicillin-resistance on day 1, 40 % 
ampicillin-resistance on day 2, 56 % ampicillin-
resistance on day 3 and 84 % ampicillin-
resistance on day 4. From the result, there was 
increasing resistance over time. The AmpR 
transfer efficiency was high. The highly self-
transmissible Flac plasmid tagged with Tn3 
(AmpR) in a laboratory E. coli strain has a 
transfer rate of 95.7 % ± 3.5 (Colom et al., 
2019). The plasmid has AMR genes. The 
increasing resistance could be as a result of 
conjugative transfer of the plasmid containing 
ampicillin resistance gene to other E. coli 
sensitive strains and the increasing fitness of the 
strain carrying AmpR. In an unpublished data, E. 
coli J62 lac pro trp hispFlac::Tn3 (AmpR) which 
served as positive control had about 96 % 
growth in the ampicillin plate 
 
                  Table 3: Percent plasmid transfer in ampicillin and ampicillin-free plates 
Plate Duration 
(hr) 
% growth in 
ampicillin-free plate 
% resistance in         
ampicillin plate 
A  24      100         16 
B 48      100         40 
C 72      100         56 











From the results, the nanoparticles were able to 
sustain and potentiate the antibacterial effect of 
ampicillin. We can rightly assert to a synergy 
between the drug and the chitosan particles 
(Saha et al., 2010, Porras-Comez et al., 2018). 
Chitosan, having a net positive charge could 
have induced alterations in the zeta potential of 
the cell membrane of the organisms’ 
permeability to the drug. Permeability could also 
have increased because of the mucoadhesive 
nature of chitosan. It has been reported that 
both chitosan and tripolyphosphate when 
combined with b-lactam drugs form 
nanostructures with antibacterial activity against 
S. aureus with different degrees of resistance. 
(Ciro et al., 2019). We can also see that 
increasing the concentration of TPP increased 
the antibacterial effect of the chitosan with Batch 
C having the highest IZD against all the 
organsisms. CS-TPP nanoparticles have a 
larger surface area so that nanoparticles can be 
tightly absorbed onto the surface of the bacteria 
cells so as to disrupt the membrane, which 
would lead to the leakage of intracellular 
components, thus killing the bacteria cells. The 
IZD in all the batches showed sensitivity to the 
ampicillin-loaded chitosan nanoparticles. 
 
CONCLUSION 
The chitosan nanoparticles had relatively good 
encapsulation efficiency and displayed slow 
drug release with good potentials to potentiate 
the antibacterial effect of ampicillin against E. 
coli J62 lac pro trp hispFlac::Tn3 (AmpR). 
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